At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition" report has been added to ...

With a steadfast dedication to client satisfaction, UI Pharmaceuticals supports innovation and excellence in contract pharmaceutical manufacturing and testing. UI Pharmaceuticals serves pharmaceutical ...

ProBioGen has expanded both protein and virus manufacturing at its Berlin headquarters—including the commissioning of an additional 1000L-scale GMP production line for proteins and the completion of ...

Korean contract development and manufacturing organizations (CDMOs) are set to engage with global drugmakers at the upcoming ...

The publisher has been closely monitoring the various markets in Saudi Arabia. This report provides a comprehensive analysis, detailing market size, forecast, trends, growth drivers, and challenges.

Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services. The ...

Forecast: Pharma and healthcare mutual funds have topped with an average return of 38.05% in 2024. HDFC Pharma and Healthcare ...

Piramal Pharma's Contract Development and Manufacturing Organisation segment, which contributes 58% to its revenue, is the company’s growth engine, as stated in the report. Its advantages include: A ...

Drospirenone (Slynd, Slinda, Lyzbet) is a synthetic spironolactone analogue with anti-mineralocorticoid activity. It is formulated as film coated tablets and coated tablets, tablets for oral route of ...